Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial (Q34616506)

3 August 2017

Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial (English)

1 reference

3 August 2017

phase II clinical trial

0 references

0 references

1 reference

1 reference

Carlo L Acerini

13

0 references

Roman Hovorka

object named as

Roman Hovorka

1

0 references

David B. Dunger

object named as

David B Dunger

14

0 references

Craig Kollman

7

object named as

Craig Kollman

1 reference

3 August 2017

Janet M Allen

2

1 reference

3 August 2017

Daniela Elleri

3

1 reference

3 August 2017

Ludovic J Chassin

4

1 reference

3 August 2017

Julie Harris

5

1 reference

3 August 2017

Dongyuan Xing

6

1 reference

3 August 2017

Tomas Hovorka

8

1 reference

3 August 2017

Anne Mette F Larsen

9

1 reference

3 August 2017

Marianna Nodale

10

1 reference

3 August 2017

Alessandra De Palma

11

1 reference

3 August 2017

Malgorzata E Wilinska

12

1 reference

3 August 2017

language of work or name

English

0 references

publication date

4 February 2010

1 reference

3 August 2017

1 reference

3 August 2017

375

1 reference

3 August 2017

9716

1 reference

3 August 2017

743-751

1 reference

Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT).

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961998-X

7 January 2021

The impact of a decade of changing treatment on rates of severe hypoglycemia in a population-based cohort of children with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961998-X

7 January 2021

Continuous glucose monitoring: roadmap for 21st century diabetes therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961998-X

7 January 2021

Continuous glucose monitoring and intensive treatment of type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961998-X

7 January 2021

Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961998-X

7 January 2021

Continuous glucose monitoring and closed-loop systems

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961998-X

7 January 2021

Closed-loop insulin delivery - what lies between where we are and where we are going?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961998-X

7 January 2021

Artificial beta-cell: clinical experience toward an implantable closed-loop insulin delivery system.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961998-X

7 January 2021

A critical assessment of algorithms and challenges in the development of a closed-loop artificial pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961998-X

7 January 2021

Hierarchy of individual calibration levels for heart rate and accelerometry to measure physical activity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961998-X

7 January 2021

Comparison of the numerical and clinical accuracy of four continuous glucose monitors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961998-X

7 January 2021

Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961998-X

7 January 2021

Grading system to assess clinical performance of closed-loop glucose control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961998-X

7 January 2021

Preventing hypoglycemia using predictive alarm algorithms and insulin pump suspension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961998-X

7 January 2021

Incidence and predictive criteria of nocturnal hypoglycemia in young children with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961998-X

7 January 2021

Detection of hypoglycemia by children with type 1 diabetes 6 to 11 years of age and their parents: a field study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961998-X

7 January 2021

Feasibility of automating insulin delivery for the treatment of type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961998-X

7 January 2021

Glucose requirements to maintain euglycemia after moderate-intensity afternoon exercise in adolescents with type 1 diabetes are increased in a biphasic manner.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961998-X

7 January 2021

Detection of hypoglycemia with continuous interstitial and traditional blood glucose monitoring using the FreeStyle Navigator Continuous Glucose Monitoring System.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961998-X

7 January 2021

Response to nocturnal alarms using a real-time glucose sensor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961998-X

7 January 2021

Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961998-X

7 January 2021

On-line adaptive algorithm with glucose prediction capacity for subcutaneous closed loop control of glucose: evaluation under fasting conditions in patients with Type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961998-X

7 January 2021

Insulin treatment in children and adolescents.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961998-X

7 January 2021

Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961998-X

7 January 2021

10.1016/S0140-6736(09)61998-X

Identifiers

DOI

1 reference

3 August 2017

1 reference